Central Trust Company’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,166
Closed -$949K 1318
2021
Q2
$949K Sell
5,166
-306
-6% -$56.2K 0.03% 312
2021
Q1
$837K Sell
5,472
-7,158
-57% -$1.09M 0.03% 321
2020
Q4
$1.97M Sell
12,630
-7,280
-37% -$1.14M 0.08% 196
2020
Q3
$2.28M Sell
19,910
-23
-0.1% -$2.63K 0.1% 155
2020
Q2
$2.24M Sell
19,933
-206
-1% -$23.1K 0.11% 148
2020
Q1
$1.81M Buy
20,139
+4,622
+30% +$415K 0.11% 151
2019
Q4
$1.68M Sell
15,517
-2,056
-12% -$222K 0.09% 188
2019
Q3
$1.72M Sell
17,573
-2,502
-12% -$245K 0.1% 177
2019
Q2
$2.44M Buy
20,075
+7,403
+58% +$899K 0.14% 144
2019
Q1
$1.71M Buy
+12,672
New +$1.71M 0.1% 168
2017
Q2
Sell
-114
Closed -$14K 1325
2017
Q1
$14K Buy
114
+39
+52% +$4.79K ﹤0.01% 935
2016
Q4
$9K Sell
75
-10
-12% -$1.2K ﹤0.01% 1013
2016
Q3
$10K Sell
85
-663
-89% -$78K ﹤0.01% 952
2016
Q2
$87K Sell
748
-694
-48% -$80.7K 0.01% 559
2016
Q1
$201K Sell
1,442
-3,758
-72% -$524K 0.02% 432
2015
Q4
$992K Sell
5,200
-183
-3% -$34.9K 0.08% 200
2015
Q3
$842K Sell
5,383
-144
-3% -$22.5K 0.07% 227
2015
Q2
$999K Buy
5,527
+1,112
+25% +$201K 0.08% 221
2015
Q1
$765K Buy
4,415
+350
+9% +$60.6K 0.06% 236
2014
Q4
$752K Buy
4,065
+260
+7% +$48.1K 0.06% 237
2014
Q3
$631K Sell
3,805
-12
-0.3% -$1.99K 0.05% 263
2014
Q2
$596K Buy
3,817
+1,037
+37% +$162K 0.05% 276
2014
Q1
$423K Buy
2,780
+2,730
+5,460% +$415K 0.04% 320
2013
Q4
$7K Sell
50
-25
-33% -$3.5K ﹤0.01% 1002
2013
Q3
$9K Hold
75
﹤0.01% 973
2013
Q2
$7K Buy
+75
New +$7K ﹤0.01% 977